ROBERT BRESALIER to CTLA-4 Antigen
This is a "connection" page, showing publications ROBERT BRESALIER has written about CTLA-4 Antigen.
Connection Strength
0.031
-
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2019 04 02; 7(1):93.
Score: 0.031